Oren Shuster

International medical cannabis company IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) announced its financial results on Thursday for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). “While the 66%...

Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through the sale of roughly 625,000 units. What Happened: Each unit will be comprised of one share and one...

Spain Unveils Framework For Prescribing Cannabis-Based Medications Spain’s Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of Cannabis. The news comes after...

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million ($10.8 million) in the second quarter of 2023. The...

Lifeist Finalizes Sale of Australian Vaporizers Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF) said on Wednesday it has sold Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:FLGC). The sale, first announced in September 2023, was...

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter of last year. Oren Shuster, the company's CEO, said IM Cannabis...

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) announced its financial and operational results on Thursday for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36...

The Israel Ministry of Health announced the anticipated reform of medical cannabis regulations in the country in August, which was expected to come into effect on Dec. 29, 2023. However, due to the Israel-Hamas war, the anticipated implementation of the medical cannabis regulatory reform has been...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Monday for the period ending June 30, 2023. The company's revenue stayed stable with a 4% year-over-year increase to CA$13.2 million ($9.8 million) for the period. Q2 2023 Financial...

Cannabis companies in the U.S. and Canada are capitalizing on the expanding European market as attitudes toward cannabis products continue to evolve and regulatory frameworks become more favorable. That’s just one of many topics that will be discussed by top CEOs, investors, and leaders...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of CA$13.2 million ($9.8 million) compared to CA$13 million in the first quarter of 2022, an increase of 1%. Q1 2023 Financial Results Gross profit was...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) FY 2022 revenues from continuing operations were CA$54.3 million, an increase of 60% compared to CA$34.1 million in 2021. Q4 Financial Highlights Revenues from continuing operations for Q4 2022 were CA$14.5 million, compared to CA$9.9 million in Q4 2021...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) will be reducing its workforce in Israel by 20%-25% across all functions to strengthen its focus on core activities and drive efficiencies to realize sustainable profitability. All actions associated with the workforce reduction are expected to be...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) has closed the first tranche of its non-brokered private placement, of 400,000 units of the company at a price of $1.25 per unit for aggregate proceeds of $500,000. Each unit consists of one common share of the company and one common share purchase...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) announced a non-brokered private placement of a minimum of 400,000 units and a maximum of 2.96 million units of the company at a price of $1.25 per unit for aggregate gross proceeds of a minimum of $500,000 and a maximum of $3.7 million, which will be...